AMENDED AND RESTATED SERVICES AGREEMENTAnd Restated Services Agreement • June 11th, 2019 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of June 10, 2019, by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (the “Service Provider”), Axovant Sciences GmbH, a company with limited liability organized under the laws of Switzerland (“ASG”), Axovant Sciences, Inc. (f/k/a Roivant Neurosciences, Inc.), a corporation organized under the laws of the State of Delaware (“ASI”), and Axovant Gene Therapies Ltd. (f/k/a Axovant Sciences Ltd., f/k/a Roivant Neurosciences Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“ASL,” and together with ASI and ASG, the “Service Recipients” and each a “Service Recipient”).
AMENDED AND RESTATED SERVICES AGREEMENTAmended and Restated Services Agreement • June 11th, 2019 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
This Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of June 10, 2019, by and among Roivant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“Service Provider”) and Axovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“ASG”, and together with any Additional Service Recipient, the “Service Recipients” and each a “Service Recipient”).
RE: Agreement and General ReleaseAxovant Gene Therapies Ltd. • June 11th, 2019 • Pharmaceutical preparations • New York
You have resigned your employment with Axovant Sciences, Inc. effective February 15, 2019 (the “Termination Date”). This Agreement and General Release (this “Agreement”) sets forth the terms and conditions under which Axovant Sciences, Inc. is offering you additional pay and benefits, including with respect to your unvested equity awards, in exchange for you making and honoring certain commitments, including your agreement not to pursue legal action against the Company as described in Sections 7 and 8.
